Close
Help
Home Journals Subjects About My LA Reviewers Authors News Submit
.
(close)

(Ctrl-click to select multiple journals)


How should we address you?

Your email address


Enter the three character code
Visual CAPTCHA
Privacy Statement

Musculoskeletal disorders

Get Updates

Musculoskeletal disorders research articles, Musculoskeletal disorders research article, Musculoskeletal disorders journals, Musculoskeletal disorders journal, Musculoskeletal disorders articles, Research on Breast cancer, Musculoskeletal disorders



Sign up for free journal updates
How should we address you?
Your email address
Enter the three character code
Visual CAPTCHA

peer reviewed open access journals 80




Latest news
  • Interview with Clinical Medicine Insights: Oncology editorial board member Prof. M. Wasif Saif
  • - 18/Jun/2010
  • Interview with Biomarkers in Cancer editorial board member Dr Xiaofeng Zhou
  • - 18/Jun/2010
  • Interview with Microbiology Insights editorial board member Dr Viroj Wiwanitkit
  • - 18/Jun/2010
  • Interview with Cell & Tissue Transplantation & Therapy editorial board member Dr Terje Forslund
  • - 17/Jun/2010
  • Interview with Nutrition and Metabolic Insights editorial board member Prof.Abdulaziz I.AL-Othaimeen
  • - 17/Jun/2010
  • Interview with Biomarker Insights editorial board member Dr Steven R. Myers
  • - 16/Jun/2010
  • Interview with Immunology and Immunogenetics Insights editorial board member Dr Robert Yarchoan
  • - 16/Jun/2010
  • Interview with International Journal of Tryptophan Research editorial board member Dr Martin Reuter
  • - 15/Jun/2010
  • Interview with Cancer Informatics editorial board member Dr Philip Crooke
  • - 15/Jun/2010
  • Interview with Environmental Health Insights editorial board member Dr Lalita Bharadwaj
  • - 15/Jun/2010
  • Interview with Integrative Medicine Insights editorial board member Dr Merrijoy Kelner
  • - 15/Jun/2010
  • Interview with Clinical Medicine Insights: Reproductive Health editorial board member Dr Lior Lowenstein
  • - 15/Jun/2010
  • Interview with Clinical Medicine Insights: Trauma and Intensive Medicine editorial board member Dr Michael Y. Wang
  • - 09/Jun/2010
  • Interview with Environmental Health Insights editorial board member Dr Lars Carlsen
  • - 09/Jun/2010
  • Interview with Evolutionary Bioinformatics editorial board member Dr Carsten Wiuf
  • - 04/Jun/2010
  • Interview with Translational Oncongenomics Editor in Chief Dr Michael Spinella
  • - 04/Jun/2010
  • Interview with Cancer Informatics editorial board member Dr Jimmy T. Efird
  • - 04/Jun/2010
  • Interview with Journal of Cell Death editorial board member Dr Hardy Kornfeld
  • - 04/Jun/2010
  • Interview with Journal of Cell Death editorial board member Dr Bruce S. Bochner
  • - 03/Jun/2010
  • Interview with Cancer Informatics editorial board member Dr Bradley J Erickson
  • - 03/Jun/2010
  • Biomarker Insights Editor in Chief co-author of Nature cover story
  • - 06/May/2010
  • Author interview with Dr Esther Uña Cidón
  • - 26/Apr/2010
  • Author interview with Dr Thomas Ostermann
  • - 24/Mar/2010
  • Author interview with Dr Yoshihito Yokoyama
  • - 11/Mar/2010

Latest pictures




Latest articles

Most read articles


(previous 30 days)Site updates
50
Articles published:
0
Comments:
23
Blog entries:
Get Updates
Get Updates
Abstract
Full-text PDF

Muscle Functions in Polymyalgia Rheumatica and Giant-Cell Arteritis     (17/Jun/2010)


Objectives: To find out whether and to what extent the muscle functions are impaired in polymyalgia rheumatica (PMR) patients in relation to duration, activity and treatment of the disease as well as any history of giant cell-arteritis (GCA). Methods: Comprehensive clinical examinations of PMR patients (N = 40) called to participate...


Abstract
Full-text PDF

Zoledronic Acid Once-yearly: What Role in the Prevention of Non-vertebral Osteoporotic Fractures?     (02/Jun/2010)


Osteoporosis is the most common bone disease. Low levels of oestrogens or testosterone are risk factors for primary osteoporosis. The most common cause of secondary osteoporosis is glucocorticoid treatment, but there are many other secondary causes of osteoporosis. Osteoporosis can be secondary to anti-oestrogen treatment for hormone-sensitive breast cancer and...


Abstract
Full-text PDF

Autonomic Dysfunction Predicts Early Cardiac Affection in Patients with Systemic Sclerosis     (24/May/2010)


Objective: To detect the early preclinical alterations in cardiac autonomic control as well as altered cardiac function in systemic sclerosis (SSc) patients and their relevance to the clinical features of the disease using noninvasive methods. Methods: 30 SSc patients and 15 healthy controls matched for age and sex underwent clinical...


Article: Intractable Chronic Low-Back Pain Caused by Ligamentopathia Treated Using a Spinous Process Plate (S-plate)
Full-text PDFAbstract

Intractable Chronic Low-Back Pain Caused by Ligamentopathia Treated Using a Spinous Process Plate (S-plate)     (10/Mar/2010)


We report a case of intractable chronic low-back pain in a gymnast that was caused by ligamentopathia in the interspinous region of the lumbar vertebrae. Sprained interspinous ligaments are a common mechanical cause of acute low-back pain in athletes. Although conservative therapy is generally effective in such cases, in this case it was not. The patient experienced severe low-back pain during lumbar flexion with tension between the L5/S interspinous ligaments. We performed interspinous fixation by...


Abstract
Full-text PDF

Introductory Editorial     (10/Feb/2010)


Introductory Editorial by Dr Karna Dev Bardhan


Abstract
Full-text PDF

Pharmacotherapy of Bone Loss in Postmenopausal Women: Focus on Denosumab     (09/Sep/2009)


Denosumab is a human monoclonal antibody against RANKL. This antibody decreases bone turnover markers and increases bone mineral density (BMD) in postmenopausal women. In phase 3 studies including more than 1100 women, denosumab achieved greater increases in lumbar spine, total hip, distal 1/3 radius, and total BMD than alendronate 70...


Abstract
Full-text PDF

Safety and in vivo Expression of a GNE-Transgene: A Novel Treatment Approach for Hereditary Inclusion Body Myopathy-2     (08/May/2009)


Hereditary inclusion body myopathy-2 (HIBM2) is an adult-onset, muscular disease caused by mutations in the GNE gene. HIBM2-associated GNE mutations causing hyposialyation have been proposed to contribute to reduced muscle function in patients with HIBM2, though the exact cause of this disease is unknown. In the current studies we examined...


Abstract
Full-text PDF

Strength, Size, and Muscle Quality in the Upper Arm Following Unilateral Training in Younger and Older Males and Females     (07/May/2009)


Purpose: To assess strength, size, and muscle quality differences between younger and older males and females in response to training. Methods: The bicep and tricep of the non-dominant arm were trained for twelve weeks in younger and older males and females (n = 41). The bicep of both arms...


Abstract
Full-text PDF

Barriers to Healthcare in a Multiethnic Cohort of Systemic Lupus Erythematosus (SLE) Patients: Patient and Physician Perceptions     (20/Apr/2009)


Objective: Barriers to medical care may influence health status. It is unclear whether problems with access can predict clinical outcomes in lupus. This study aimed to determine whether care barriers are associated with increased disease activity and damage in a multi-center, multiethnic SLE cohort. We also compared concordance between care...


Abstract
Full-text PDF

A Comprehensive Clinicopathologic Analysis Suggests that Vascular Endothelial Growth Factor (VEGF) is the Most Likely Mediator of Periosteal New Bone Formation (PNBF) Associated with Diverse Etiologies     (23/Jul/2008)


Periosteal new bone formation (PNBF) is the means by which appositional bone growth normally takes place on the surfaces of compact bone. Alterations in the periosteal microenvironment trigger complex interactions between osteoblasts and endothelial cells to promote PNBF. Physiologic processes like mechanical stress result in normal PNBF; but, a variety...


Abstract
Full-text PDF

Cartilage-Specific Matrix and Integrin Expression in Three-Dimensional Articular Chondrocyte Cultures Overexpressing Human Interleukin-10     (16/May/2008)


Riccarda D. Müller1, Thilo John1, Benjamin Kohl1, Anja Feldner1, Hala Zreiqat2, Wolfgang Ertel1, Drake LaFace3, Beth Hutchins3, Andreas Oberholzer4 and Gundula Schulze-Tanzil1,5 1Charité-University of Medicine, Campus Benjamin Franklin, Berlin, Dep. of Trauma and Reconstructive Surgery, FEM, Krahmerstrasse 6–10, 12207 Berlin, Germany.  2Tissue Engineering and Biomaterials Research Unit, Biomedical Engineering,...


Abstract
Full-text PDF

Pharmacodynamic/Pharmacogenomic Modeling of Insulin Resistance Genes in Rat Muscle After Methylprednisolone Treatment: Exploring Regulatory Signaling Cascades     (23/Apr/2008)


Zhenling Yao1, Eric P. Hoffman3, Svetlana Ghimbovschi3, Debra C. DuBois1,2, Richard R. Almon1,2 and William J. Jusko1 1Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, 2Department of Biological Sciences, State University of New York at Buffalo, Buffalo, New York. 3Children’s National Research Center, Washington D.C. Abstract...


Abstract
Full-text PDF

Skin Infection by Coagulase Negative Staphylococci as a Potential Triggering Factor for Cutaneous Leukocytoclastic Vasculitis     (21/Apr/2008)


Rene Thonhofer, Markus Trummer, Cornelia Siegel and Elisabeth Uitz Department of Internal Medicine, State Hospital Muerzzuschlag, Austria. Abstract Introduction: Leukocytoclastic vasculitis (LV) is a necrotising vasculitis of the small dermal blood vessels, clinically presented as palpable purpura. It is a heterogeneous disorder often limited to the skin...


Abstract
Full-text PDF

Expression of Osteoarthritis Marker YKL-39 is Stimulated by Transforming Growth Factor Beta (TGF-beta) and IL-4 in Differentiating Macrophages     (14/Feb/2008)


Alexei Gratchev, Christina Schmuttermaier, Srinivas Mamidi, LiMing Gooi, Sergij Goerdt and Julia Kzhyshkowska Department of Dermatology, University Medical Centre Mannheim, Ruprecht-Karls University of Heidelberg, Mannheim, Germany D-68167. Abstract YKL-39 is a Glyco_18 domain containing chitinase-like protein which is currently recognized as a biomarker for the activation of chondrocytes...


Abstract
Full-text PDF

Critical Involvement of Cytokines and Chemokines in the Pathogenesis of Rheumatoid Vasculitis     (09/Feb/2008)


Tsuyoshi Kasama, Takeo Isozaki, Kuninobu Wakabayashi, Tsuyoshi Odai and Mizuho Matsunawa From the Division of Rheumatology and Clinical Immunology, Department of Internal Medicine, Showa University School of Medicine, Tokyo, Japan. Abstract Vasculitis in rheumatoid arthritis (rheumatoid vasculitis) has a heterogeneous clinical presentation that includes skin disorders, neuropathy, eye...


Abstract
Full-text PDF

The Clinical Application of Anti-CCP in Rheumatoid Arthritis and Other Rheumatic Diseases     (03/May/2007)


CT Chou1, HT Liao2, CH Chen2, WS Chen1, HP Wang1 and KY Su1 1Division of Allergy-Immunology-Rheumatology, Veterans General Hospital, 2Division of Allergy-Immunology-Rheumatology, Wan Fang Hospital, Taipei, Taiwan.Abstract: Rheumatoid arthritis (RA) is a common rheumatic disease in Caucasians and in other ethnic groups. Diagnosis is mainly based on clinical features. Before...


Abstract
Full-text PDF

Accelerators of Osteogenesis by Recombinant Human Bone Morphogenetic Protein-2     (21/Feb/2007)


Yasunori Okubo1, Kenji Kusumoto2 and Kazuhisa Bessho11Department of Oral and Maxillofacial Surgery, Graduate School of Medicine, Kyoto University, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan. 2Department of Plastic and Reconstructive Surgery, Kansai Medical University, 10-15 Fumizono-cho, Moriguchi, Osaka, 570-8507, Japan.Abstract: Bone morphogenetic protein (BMP) appears to be one of the...


Abstract
Full-text PDF

Do We Need Biomarkers for Disc Degeneration?     (07/Feb/2007)


Helen E. Gruber and Edward N. Hanley, Jr. Department of Orthopaedic Surgery, Carolinas Medical Center, Charlotte, N.C.Abstract: Disc degeneration plays a major role in this country's medical, social and economic structure. The life-time prevalence of low back pain, which has disc degeneration as its cause, is about 80% in the...


Abstract
Full-text PDF

Serum C-Reactive Protein (CRP), Target for Therapy or Trouble?     (07/Feb/2007)


Virginia B. Kraus1 and Joanne M. Jordan2 1Duke University Medical Center, Durham, NC 27710; 2Thurston Arthritis Research Center, University of North Carolina, Chapel Hill, NC 27599.Abstract: High sensitivity serum C-reactive protein (hs-CRP) has come into clinical use as a marker of risk for cardiovascular disease (CVD). In addition to a...


Abstract
Full-text PDF

Collagen Biomarkers for Arthritis Applications     (07/Feb/2007)


James D. Birmingham1, Vladimir Vilim2 and Virginia B. Kraus1 1Duke University Medical Center, Durham, North Carolina, USA; 2Institute of Rheumatology, Prague, Czech Republic.Background: The most common form of chronic arthritis is osteoarthritis (OA) with prevalence as high as 80% after age 75 (Arden and Nevitt, 2006). The incidence of OA...